On (b)(6) 2008, a 25mm trifecta valve was implanted.The patient developed severe prosthetic aortic stenosis, aortic insufficiency, and regurgitation.On (b)(6) 2016, redo-avr replacement for macce (major adverse cardiovascular and cerebrovascular event) reduction was performed.The patient underwent urgent inpatient redo-sternotomy and redo-avr for structural valve degeneration.Per report, the patient is doing well 2 months post redo-avr, and is able to walk with some shortness of breath.No recurrent angina reported.(study patient id: (b)(4)).
|
Product evaluation: an event of "prosthetic aortic stenosis, aortic insufficiency, and regurgitation" was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported incident could not be conclusively determined.
|